Comparing two versions of a study drug
Part of Digestive system clinical trials.
This trial compares two forms of a study drug to see how they are absorbed and cleared from the body, and to check their safety. It is for healthy volunteers and may help the company decide which version to develop further.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 19 and 50 years old.
- You are a healthy volunteer.
- Your weight is between 50 and 90 kg (about 110 to 198 pounds).
- Your body mass index (BMI) is between 18.5 and 29.9.
- You have a negative test for Helicobacter pylori (a stomach bacteria) at screening.
- You are able to undergo a tube placed in your stomach for acid monitoring (pH catheter).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment called Afluxin for people with gastroesophageal reflux disease (GERD), which causes heartburn and regurgitation. It aims to see if Afluxin is safe and works better than a placebo (inactive control) to relieve symptoms.
This trial tests two similar study drugs to see how they compare in terms of safety and how the body processes them. It is for healthy adults who want to help with early-stage medication research.
This study compares three different versions of a medicine to see how they act in the body and how safe they are. Healthy adults take the medicine by mouth several times so researchers can compare them.
This trial compares two versions of a medicine (AD-116A and AD-1161) to see if they work the same in the body when taken after eating. It is for healthy adult men to help ensure the new version is as good as the original.
This trial tests a new drug (AD-115A or AD-1151) in healthy volunteers to see how safe it is and how the body processes it. If you qualify, you'll receive a single dose and be monitored closely.
This trial tests if two different versions of the study drug AD-116A work the same way in the body. It only includes healthy adult men, so it's not a treatment for a specific disease but helps confirm the drug's safety and absorption.
Hear when a new Gastroesophageal Reflux Disease (GERD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.